Age, gender, quadriceps strength and hop test performance are the most important factors affecting the achievement of a patient-acceptable symptom state after ACL reconstruction.


Journal

Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA
ISSN: 1433-7347
Titre abrégé: Knee Surg Sports Traumatol Arthrosc
Pays: Germany
ID NLM: 9314730

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 06 02 2019
accepted: 17 06 2019
pubmed: 24 6 2019
medline: 25 6 2020
entrez: 24 6 2019
Statut: ppublish

Résumé

To assess the percentage of patients achieving an acceptable symptom state 2 years after primary anterior cruciate ligament reconstruction (ACLR) and to identify factors affecting its achievement, in a large cohort. Patients who underwent primary ACLR at Capio Artro Clinic, Stockholm, Sweden, from 2005 to 2015, were identified in our clinic registry. Patients who had completed the Knee injury and Osteoarthritis Outcome Score (KOOS) at the 2-year follow-up were included. The primary outcome was the achievement of a patient-acceptable symptom state (PASS) for each KOOS subscale. A multivariate logistic regression analysis was used to determine whether patient age, gender, time from injury to surgery, pre-injury Tegner activity level, graft type, cartilage injury, the presence of medial meniscus (MM) or lateral meniscus (LM) resection or repair and the recovery of 6-month symmetrical (limb symmetry index [LSI] of ≥ 90%) isokinetic quadriceps or hamstring strength and single-leg-hop test performance were factors associated with the achievement of a PASS for each KOOS subscale. A total of 2335 primary ACLRs were included. More than 60% of the patients reported a PASS on four of the five KOOS subscales. Age ≥ 30 years and an LSI of ≥ 90% for 6-month isokinetic quadriceps strength increased the odds of achieving a PASS across all KOOS subscales. Female gender reduced the odds of achieving a PASS on the Pain (OR 0.76; 95% CI 0.62-0.94; P = 0.01), activities of daily living (ADL) (OR 0.79; 95% CI 0.64-0.97; P = 0.02) and sport and recreation (OR 0.72; 95% CI 0.58-0.89; P = 0.003) subscales. The presence of an MM repair reduced the odds of achieving a PASS on the Pain (OR 0.59; 95% CI 0.36-0.96; P = 0.03) subscale. Hamstring tendon (HT) autograft rather than bone-patellar tendon-bone (BPTB) autograft showed increased odds (OR 2.02; 95% CI 1.31-3.10; P = 0.001), whereas a cartilage injury showed reduced odds (OR 0.73; 95% CI 0.55-0.97; P = 0.03) of achieving a PASS on the sport and recreation subscale. An LSI of ≥ 90% for 6-month single-leg-hop test performance increased the odds of achieving a PASS on the ADL (OR 1.37; 95% CI 1.09-1.71; P = 0.005), Sport and Recreation (OR 1.40; 95% CI 1.11-1.77; P = 0.004), and quality of life (OR 1.28; 95% CI 1.00-1.63; P = 0.04) subscales. More than 60% of the patients reported an acceptable symptom state on four of the five KOOS subscales 2 years after primary ACLR. Age ≥ 30 years and female gender were the non-modifiable factors that consistently increased and reduced, respectively, the odds of achieving a PASS. A symmetrical 6-month isokinetic quadriceps strength and single-leg-hop test performance were the modifiable factors that consistently increased the opportunity of achieving a PASS 2 years after primary ACLR. III.

Identifiants

pubmed: 31230125
doi: 10.1007/s00167-019-05576-2
pii: 10.1007/s00167-019-05576-2
pmc: PMC6994649
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

369-380

Références

Am J Sports Med. 2012 Oct;40(10):2342-7
pubmed: 22962297
Am J Sports Med. 2016 Jan;44(1):242-54
pubmed: 25802119
Am J Sports Med. 1991 May-Jun;19(3):210-5; discussion 215-6
pubmed: 1867329
Knee Surg Sports Traumatol Arthrosc. 2018 Aug;26(8):2270-2277
pubmed: 29492642
Am J Sports Med. 2014 May;42(5):1058-67
pubmed: 24647881
Am J Sports Med. 2015 Aug;43(8):1902-7
pubmed: 25977523
Am J Sports Med. 2012 Oct;40(10):2230-5
pubmed: 22962296
Knee. 2015 Mar;22(2):100-10
pubmed: 25547048
Clin Biomech (Bristol, Avon). 2007 Jun;22(5):543-50
pubmed: 17391820
Am J Sports Med. 2010 Aug;38(8):1542-8
pubmed: 20551284
Am J Sports Med. 2016 May;44(5):1215-24
pubmed: 26912282
Am J Sports Med. 2000 Jul-Aug;28(4):446-52
pubmed: 10921633
J Bone Joint Surg Br. 2012 Dec;94(12):1649-54
pubmed: 23188906
Knee Surg Sports Traumatol Arthrosc. 2019 Feb;27(2):381-388
pubmed: 29955930
Knee Surg Sports Traumatol Arthrosc. 1999;7(3):146-51
pubmed: 10401650
Am J Sports Med. 2018 Oct;46(12):2851-2858
pubmed: 30102869
Knee Surg Sports Traumatol Arthrosc. 2011 Nov;19(11):1798-805
pubmed: 21932078
Knee Surg Sports Traumatol Arthrosc. 2014 Feb;22(2):379-86
pubmed: 24318509
Am J Sports Med. 2012 Oct;40(10):2348-56
pubmed: 22926749
Am J Sports Med. 2014 May;42(5):1049-57
pubmed: 24644301
Arthroscopy. 2014 Jul;30(7):803-10
pubmed: 24746404
J Strength Cond Res. 2002 Nov;16(4):617-22
pubmed: 12423195
Br J Sports Med. 2009 May;43(5):323-5
pubmed: 19273472
Br J Sports Med. 2016 Aug;50(15):946-51
pubmed: 27215935
Knee. 2011 Oct;18(5):287-93
pubmed: 20850327
Knee Surg Sports Traumatol Arthrosc. 2018 Aug;26(8):2251-2258
pubmed: 29134251
Orthop J Sports Med. 2018 Apr 25;6(4):2325967118764317
pubmed: 29780834
Am J Sports Med. 2003 Jul-Aug;31(4):564-73
pubmed: 12860546
Am J Sports Med. 2016 Nov;44(11):2820-2826
pubmed: 27474383
Am J Sports Med. 2015 Jul;43(7):1591-7
pubmed: 25868635
Knee Surg Sports Traumatol Arthrosc. 2018 Oct;26(10):2966-2977
pubmed: 29404655
J Orthop Sports Phys Ther. 1998 Aug;28(2):88-96
pubmed: 9699158
Am J Sports Med. 2010 Jul;38(7):1334-42
pubmed: 20410376
Phys Ther. 2007 Mar;87(3):337-49
pubmed: 17311886
Orthop J Sports Med. 2015 Mar 10;3(3):2325967115573706
pubmed: 26665029
Knee Surg Sports Traumatol Arthrosc. 2017 May;25(5):1356-1363
pubmed: 26205480
Knee Surg Sports Traumatol Arthrosc. 2018 Feb;26(2):426-433
pubmed: 28918506
Br J Sports Med. 2016 Jul;50(13):804-8
pubmed: 27162233
Knee Surg Sports Traumatol Arthrosc. 2017 Aug;25(8):2481-2487
pubmed: 26724828
Clin Orthop Relat Res. 1985 Sep;(198):43-9
pubmed: 4028566
Am J Sports Med. 2014 Oct;42(10):2386-92
pubmed: 25106782
Am J Sports Med. 2013 Mar;41(3):535-43
pubmed: 23371474
Am J Sports Med. 2017 Jul;45(9):2085-2091
pubmed: 28714793
Knee Surg Sports Traumatol Arthrosc. 2013 Apr;21(4):914-27
pubmed: 22885701
J Orthop Sports Phys Ther. 1998 Jul;28(1):23-31
pubmed: 9653687
Knee Surg Sports Traumatol Arthrosc. 2013 Sep;21(9):1967-76
pubmed: 23100047

Auteurs

Riccardo Cristiani (R)

Department of Molecular Medicine and Surgery, Stockholm Sports Trauma Research Center, Karolinska Institutet, Stockholm, Sweden. riccardo.cristiani87@gmail.com.
Capio Artro Clinic, FIFA Medical Centre of Excellence, Sophiahemmet Hospital, Valhallavägen 91, 11486, Stockholm, Sweden. riccardo.cristiani87@gmail.com.

Christina Mikkelsen (C)

Department of Molecular Medicine and Surgery, Stockholm Sports Trauma Research Center, Karolinska Institutet, Stockholm, Sweden.
Capio Artro Clinic, FIFA Medical Centre of Excellence, Sophiahemmet Hospital, Valhallavägen 91, 11486, Stockholm, Sweden.

Gunnar Edman (G)

Department of Molecular Medicine and Surgery, Stockholm Sports Trauma Research Center, Karolinska Institutet, Stockholm, Sweden.

Magnus Forssblad (M)

Department of Molecular Medicine and Surgery, Stockholm Sports Trauma Research Center, Karolinska Institutet, Stockholm, Sweden.

Björn Engström (B)

Department of Molecular Medicine and Surgery, Stockholm Sports Trauma Research Center, Karolinska Institutet, Stockholm, Sweden.
Capio Artro Clinic, FIFA Medical Centre of Excellence, Sophiahemmet Hospital, Valhallavägen 91, 11486, Stockholm, Sweden.

Anders Stålman (A)

Department of Molecular Medicine and Surgery, Stockholm Sports Trauma Research Center, Karolinska Institutet, Stockholm, Sweden.
Capio Artro Clinic, FIFA Medical Centre of Excellence, Sophiahemmet Hospital, Valhallavägen 91, 11486, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH